Will the Phase 2 trial "A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)" reach primary completion on or before Sep 25, 2028?

Resolves Yes if ClinicalTrials.gov record NCT07116031 (Sanofi) shows an actual primary completion date on or before Sep 25, 2028. Registered date at generation: Sep 25, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Sep 25, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.